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Histones are the main protein components of eukaryotic chromatin. Histone variants and histone modifications modulate 
chromatin structure, ensuring the precise operation of cellular processes associated with genomic DNA. H3.3, an ancient and 
conserved H3 variant, differs from its canonical H3 counterpart by only five amino acids, yet it plays essential and specific 
roles in gene transcription, DNA repair and in maintaining genome integrity. Here, we review the most recent insights into the 
functions of histone H3.3, and the involvement of its mutant forms in human diseases. 
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Chromatin consists of repeating units called nucleosomes, 
which are composed of an octamer of canonical histone 
proteins H2A, H2B, H3 and H4, and 147 bp of DNA 
wrapped around the octamer (Luger et al., 1997). Histones 
possess tails on both C- and N-termini, both of which are 
subject to a great number of post-translational modifications 
(PTMs), including methylation, acetylation, phosphoryla-
tion and ubiquitination (Kouzarides, 2007). These PTMs 
play important roles in the regulation of dynamic processes 
related to nucleosomes, including nucleosome turnover and 
chromatin remodeling. As a consequence, highly specific 
chromatin states can be established to regulate DNA repli-
cation and transcription, and maintain genome stability 
(Kouzarides, 2007). In addition to the mechanisms men-
tioned above, another regulatory layer of chromatin state 
exists, namely- the exchange of canonical histones with 
histone variants. Histone variants possess characteristics 
absent from canonical histones and contribute to the regula-
tion of the structure and function of nucleosome and chro-
matin (Henikoff and Ahmad, 2005). 
In mammals, various canonical H3 as well as variant 
forms of H3 have been identified. Canonical H3 are H3.1 
and H3.2, which differ at only one amino acid residue, with 
Cys96 in H3.1 and Ser96 in H3.2 (Szenker et al., 2011). 
Apart from the canonical H3, multiple variants of H3 have 
now been identified: the replacement variant H3.3, the cen-
tromere-specific variant CENP-A, the testis-specific variant 
H3t and H3.5, and the primate-specific variants H3.X and 
H3.Y (Filipescu et al., 2013). H3.3 differs from H3.1 by 
five amino acids substitutions (S31A, A87S, I89V, G90M, 
and S96C) (Figure 1A). H3.3 Ser31 is located at N-terminal 
tail and can be phosphorylated (Hake et al., 2005). The res-
idues Ala87, Ile89 and Gly90 are located in the 2 helix of 
the histone-fold domain, and are important for H3.3 deposi-
tion at specific loci in the genome by different histone 
chaperones (Filipescu et al., 2013). In this review we will 
focus on the recent progress in our understanding of the  
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Figure 1  Genomic distribution of H3.3. A, Schematic view of the amino 
acid difference between canonical H3 (H3.1/H3.2) and replacement 
H3(H3.3), and the lysine residues enriched in the N-terminus of H3. B, 
H3.3 is deposited at various chromatin environments by either HIRA com-
plex or DAXX/ATRX. HIRA complex is responsible for the incorporation 
of H3.3 to active promoters, bivalent promoters and transcribed gene bod-
ies. H3.3 is essential for the maintenance of H3K27me3 at bivalent pro-
moters and is enriched with H3K36me3 in transcribed gene bodies. 
ATRX/DAXX deposits H3.3 to pericentromeric regions, repetitive ele-
ments and telomeres. H3.3 specific enrichment of H3K9me3 is required for 
the repression of ERVs and imprinted DMRs. 
biological functions of histone H3.3, as well as its role dur-
ing development and tumorigenesis. 
THE PROPERTIES OF H3.3 COMPARED WITH 
ITS CANONICAL COUNTERPARTS 
The expression patterns of H3.3 coding genes 
In the human species, the genes encoding H3.1 and H3.2 
lack introns and do not have a polyA signal, though they 
contain a palindromic termination element, which is in-
volved in the regulation of transcriptional termination 
(Marzluff et al., 2002). Ten H3.1 genes have been identified 
(HIST1H3A to HIST1H3J), all of which are located in the 
histone cluster 1 on chromosome 6p22-p21.3 (Marzluff   
et al., 2002). H3.2 is coded by three genes, namely 
HIST2H3A, HIST2H3C and HIST2H3D on chromosome 1 
(Marzluff et al., 2002). These H3 genes are all expressed 
simultaneously at S phase, together with the other canonical 
histone genes (Frank et al., 2003). These histones are in-
corporated into the chromatin in a DNA replication- 
dependent manner (RD). In contrast, there are only two 
H3.3 genes, namely H3F3A and H3F3B, both of which 
contain introns and a polyadenylation signal (Frank et al., 
2003). These are located on chromosome 1 and 17, respec-
tively, and have different 5′-UTR (5′ untranslated region) , 
which suggests they may be subjected to different mecha-
nisms of transcriptional regulation (Frank et al., 2003). H3.3 
is expressed and incorporated into chromatin throughout the 
entire cell cycle, through both DNA replication-dependent 
(RD) and -independent (RI) mechanisms (Ahmad and 
Henikoff, 2002). It is worth noting that H3.1 can also be 
incorporated into chromatin at DNA repair sites through 
DNA synthesis-dependent mechanisms.  
The genome-wide distribution of H3.3. 
Histone proteins, which are translated in the cytoplasm, are 
chaperoned into the nucleus for assembly into chromatin (Li 
et al., 2013). To date, numerous histone chaperones have 
been identified. For the histone H3 family, both common 
chaperones and histone form-specific chaperones are de-
scribed. Common chaperones include Asf1a, Asf1b and 
NASP, and specific chaperones include CAF1 (chromatin 
assembly factor 1), HIRA (histone cell cycle regulator), 
DAXX (death domain-associated protein) and HJURP 
(Holliday junction recognition protein) (Hamiche and 
Shuaib, 2013). Both common and specific chaperons bind 
H3 in the form of its H3/H4 hetero-dimer. NASP transports 
H3/H4 into the nucleus and supplies them to Asf1a/b, which 
in turn delivers H3.1/H4 to CAF1 or H3.3/H4 to HIRA and 
DAXX (Hamiche and Shuaib, 2013). The crystal structure 
of the DAXX-H3.3-H4 complex reveals that both Ala87 
and Gly90 of H3.3 can mediate the specific interaction be-
tween DAXX and H3.3 (Liu et al., 2012). It would be of 
great interest to also acquire the crystal structure of CAF1 
complexed with H3.1/H4 and/or HIRA complexed with 
H3.3/H4, to identify the mechanisms by which chaperones 
distinguish the minor sequence difference between canoni-
cal H3 and H3.3. 
Currently known H3.3 histone chaperones are DAXX 
complex and HIRA complex (Lewis et al., 2010; Tagami  
et al., 2004), both of which deposit H3.3 into the genome 
throughout the entire cell cycle of actively dividing cells 
and in quiescent cells (Figure 1B). In a pioneering cytolog-
ical study, using immunostaining and DNA FISH (Fluores-
cent in suit Hybridization), H3.3 was discovered to be de-
posited at specific, active chromatin regions in Drosophila 
cells (Ahmad and Henikoff, 2002). Subsequently, the re-
placement of H3.3 was studied on a genome-scale by 
ChIP-chip (chromatin immunoprecipitation (“ChIP”) with 
DNA microarray (“chip”)) method. It was found that the 
H3.3 signal covered active genes and transposons, and posi-
tively correlated with H3K4 methylation intensity and RNA 
polymerase II (RNAP II) signal. Importantly, the male X 
chromosome, which has stronger transcriptional activity 
compared to autosomes due to dosage-compensation 
(Straub et al., 2005), also displayed higher H3.3 density 
across the chromosome (Mito et al., 2007). There is, now, 
growing evidence that the HIRA complex is responsible for 
the deposition of H3.3 at actively transcribed genes. As a 
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consequence, new nucleosomes can form, ultimately ensur-
ing genome stability. Moreover, in recent studies in mouse 
ES cells using chromatin immunoprecipitation combined 
with high-resolution genome-wide sequencing (ChIP-seq), 
it was revealed that H3.3 is also enriched at a subset of in-
active genes, telomeres and repetitive elements such as en-
dogenous retroviral elements (ERVs) (Elsasser et al., 2015; 
Goldberg et al., 2010), where ATRX/DAXX is required for 
H3.3 deposition and the maintenance of a repressive chro-
matin state (Elsasser et al., 2015; Goldberg et al., 2010; 
Lewis et al., 2010; Voon et al., 2015). Meanwhile, H3.3 is 
also distributed in other regions such as cis-regulatory ele-
ments (Chen et al., 2013; Goldberg et al., 2010; Mito et al., 
2007), and plays an important part in the regulation of gene 
expression (Chen et al., 2013). However, the chaperon that 
is responsible for deposition of H3.3 at these regions re-
mains to be identified (Filipescu et al., 2013; Goldberg    
et al., 2010; Szenker et al., 2011). Taken together, these 
results suggest that H3.3 is deposited across the genome by 
dedicated chaperone pathways with respect to chromatin 
contexts (Figure 1B).  
The regulation of chromatin dynamics by variant H3.3  
Recent biochemical and biophysical studies on the stability 
of mono-nucleosomes and the dynamics of nucleosomal 
arrays have convincingly demonstrated that the presence of 
H3.3 has no effect on mono-nucleosomes’ stability (Chen  
et al., 2013; Thakar et al., 2009). Rather, it was found that 
H3.3 presence impairs the inter-fiber interactions of 
nucleosomal arrays (Chen et al., 2013). In comparison, 
H2A.Z, a H2A variant, enhances both the stability of 
mono-nucleosomes and the compaction of chromatin fibers. 
Interestingly, H3.3 incorporation overrules the effect of 
H2A.Z on chromatin compaction and results in the 
maintenance of a relatively open chromatin state (Chen   
et al., 2013). While the precise mechanisms for this 
phenomenon are unknown, it is clear that the interplay 
between histone variants is crucial for the regulation of 
chromatin function in vivo. Previously, it was reported that 
H3.3-containing chromatin regions are less resistant to salt 
extraction, a condition which suggests that a relatively open 
chromatin structure is maintained there (Henikoff et al., 
2009). In addition, nucleosomes containing H2A.Z/H3.3 
double variants are found enriched at active promoters, en-
hancers and insulator regions in human cells, and the insta-
bility of these nucleosomes facilitates the access of tran-
scription factors and co-factors to these regulatory regions 
(Jin et al., 2009). In addition, H3.3 levels at promoter 
regions are positively correlated with expression levels of 
the respective genes (Jin et al., 2009). Although ge-
nome-wide analysis has shown that there is a positive cor-
relation between H3.3 signal and transcriptional activity, 
direct evidence for a causal relationship is still lacking. 
Some hints about this correlation come from genetic studies 
in various model systems, including those of flies and mice. 
In H3f3a and H3f3b double-null adult Drosophila, gene 
expression was found to be changed at a global level. Intri-
guingly, more genes were up-regulated than down-regulated 
(Sakai et al., 2009), suggesting a repressive role of H3.3 in 
the transcriptional regulation. However, these changes were 
not specific to H3.3 as they were rescued by overexpression 
of canonical H3. This result suggests that the non-exclusive 
role that H3.3 plays in transcription is to maintain nucleo-
some density and genome stability (Sakai et al., 2009). 
However, gene expression profiling in mouse ES cells ei-
ther depleted of H3.3 or HIRA, showed minor differences 
of gene expression levels in a subset of genes when   
compared to wild type cells. Thus, H3.3 may not be    
required for maintenance of the transcriptome in all cell 
types (Banaszynski et al., 2013; Bush et al., 2013).  
In a recent study utilizing all-trans-retinoic acid (tRA) to 
induce activation of target genes, H3.3 positioned at en-
hancers was found to be essential for the rapid activation of 
target genes. It was also found that knockdown of H3.3 by 
siRNA resulted in chromatin compaction and delayed tran-
scriptional response of target genes (Chen et al., 2013). 
These results suggest that in mouse ES cells, H3.3 may 
function mainly by maintaining an open chromatin state, 
which is important for transcription initiation (Li et al., 
2010). Furthermore, H3.3 deposits at DNA damage sites 
and renders chromatin prone for later reactivation of tran-
scription once DNA repair is completed (Adam et al., 
2013). 
However, recent genome-wide studies found that H3.3 is 
also deposited at heterochromatin regions such as retroviral 
elements, telomeres and pericentromeres (Elsasser et al., 
2015; Goldberg et al., 2010). For instance, studies of mouse 
ES cells showed that the DAXX-dependent deposition of 
H3.3 at telomere regions maintains telomere integrity, a 
situation which is essential for self-renewal of these cells. 
Furthermore, to fulfill this function in ensuring telomere 
integrity, both H3.3K4 and the presence of CBX4 (HP1) 
are important (Goldberg et al., 2010; Wong et al., 2010; 
Wong et al., 2009). More recently, a genome-wide study 
revealed that ATRX-dependent H3.3 deposition is not lim-
ited to telomeres and pericentromeric regions, but also oc-
curs at imprinted loci. The interplay of ATRX and H3.3 at 
imprinted alleles is essential for the maintenance of 
H3K9me3 modification, gene repression and proper allelic 
expression (Voon et al., 2015). In another study, H3.3 was 
found to be required for the repression of key developmen-
tal genes via the recruitment of PRC2 by HIRA; further-
more, suppression of endogenous retrovirus element was 
dependent on DAXX, H3.3 and KAP1 (Banaszynski et al., 
2013; Elsasser et al., 2015). These researches suggest a 
more complex picture of H3.3 function along the genome. 
The dynamics of H3.3 turnover at the genome-wide.  
The incorporation into chromatin and eviction from chro-
matin of H3.3 during cellular activities are highly dynamic 
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processes. While conventional chromatin immunoprecipita-
tion (ChIP)-based methods measure the steady-state occu-
pancy of H3.3 at specific target regions, they provide no 
information about the kinetics or turnover of H3.3. Howev-
er, these characteristics are very important for the diverse 
function of chromatin proteins (Lickwar et al., 2012). To 
address this problem, a novel method called CATCH-IT 
(covalent attachment of tags to capture histones and identify 
turnover) was used in a recent study to determine the turn-
over rate of H3.3 along the Drosophila genome (Deal et al., 
2010). In that report, it was shown that bodies of actively 
transcribed genes, replication origins and cis-regulatory 
elements showed the highest rate of turnover. This is con-
sistent with the idea that histone turnover can assist the ac-
cessibility of the DNA to transcription or replication ma-
chinery and trans-acting factors. More interestingly, nucle-
osomes at trithorax group-binding regions turn over faster 
than those in polycomb-group protein-binding regions; this 
is consistent with the notion that trithorax group maintains 
active chromatin state while polycomb-group protein bind-
ing results in a repressive chromatin state (Steffen and 
Ringrose, 2014). In another study, the H3.3-containing nu-
cleosome turnover in a mouse fibroblast genome was cap-
tured by inducible expression of histones with epitope at 
different time points (Kraushaar et al., 2013). This study 
showed that the turnover rate along the mouse genome var-
ied greatly, falling into three categories: (i) rapid turnover at 
promoters and enhancers; (ii) intermediate turnover at gene 
bodies; and (iii) slow turnover at heterochromatic regions. 
Faster H3.3 turnover at enhancers and promoters is posi-
tively correlated with active histone modifications, includ-
ing H3K4me1, H3K4me3, H3K9ac, H3K27ac and the his-
tone variant H2A.Z, whereas slower turnover is positively 
correlated with H3K27me3 and H3K36me3 modifications. 
These results from Drosophila and mice studies indicate 
that there are distinct mechanisms for histone deposition 
and nucleosome eviction at different functional chromatin 
regions, mechanisms which are correlated with specific 
histone marks and chromatin binding proteins.  
Although H3.3 displays a highly dynamic behavior at a 
genome-wide level, it remains unknown whether the 
(H3.3-H4)2 tetramer is replaced as a unit, or as a (H3.3-H4) 
heterodimer. Using a double-induction system to control the 
expression of H3.3, Zhu and colleagues reported that while 
none of the (H3.1-H4)2 tetramers, and nearly none of 
(H3.3-H4)2 tetramers (~90%) split, the remaining 10% of 
(H3.3-H4)2 tetramers did experience splitting during DNA 
replication, and these splitting events are significantly en-
riched at the cell type-specific enhancer regions (Huang   
et al., 2013). Considering the role of enhancers in maintain-
ing cell type-specific transcription programs, the split H3.3 
nucleosomes, together with the epigenetic information as-
sociated, may serve as epigenetic memory for a specific 
transcriptional status. It is of note that, during somatic cell 
nuclear transfer (SCNT), the active transcriptional state of 
donor nuclei was retained after being transplanted into an 
enucleated egg, and H3.3 indeed appeared to be necessary 
for the maintenance of epigenetic memory (Ng and Gurdon, 
2008). Although the molecular mechanisms behind memory 
establishment remain unclear, the splitting phenomenon 
described above might represent a potential pathway for the 
inheritance of epigenetic information during cell division. 
THE FUNCTIONS OF H3.3 IN DEVELOPMENT 
The function of H3.3 in early embryo development  
H3.3 takes part in various stages of development, such as 
gametogenesis, fertilization and differentiation (Bush et al., 
2013; Lin et al., 2013; Tang et al., 2015; Wen et al., 2014a; 
Yuen et al., 2014) (Figure 2A). Knockout animal models for 
H3.3 or H3.3-specific chaperones have revealed the essen-
tial functions of H3.3 during development (Garrick et al., 
2006; Michaelson et al., 1999; Roberts et al., 2002; Tang  
et al., 2015). H3.3 is encoded by two different intron-    
containing genes in mice, H3f3a and H3f3b. The two genes 
have distinct expression patterns and regulatory regions, 
suggesting they fulfill different cellular functions (Frank et al., 
2003). H3f3a knockout mice were viable to adulthood, alt-
hough males were found subfertile; in comparison, H3f3b 
homozygotes-null mice displayed deficiencies in embryonal 
growth and did not survive birth, with H3f3b heterozygote 
males being sterile (Tang et al., 2015). In addition, a small 
percentage of homozygous H3f3b-HA knock-in mice died 
within a week after birth (Wen et al., 2014b). Although the 
cause of such lethality remains unclear, these phenomena 
indicate that H3.3 is important for early embryonic devel-
opment. Furthermore, H3f3b knockout MEF cells exhibited 
severe karyotype abnormalities, ectopic CENP-A localiza-
tion and defective chromosome segregation, thus, suggest-
ing that H3.3 is important for maintaining overall chromo-
some integrity (Bush et al., 2013).  
During Xenopus development, H3.3 expression peaks at 
gastrulation, and the depletion of H3.3 results in gastrula-
tion arrest and abnormal expression of late mesoderm 
markers (Ng and Gurdon, 2008). Knockdown of H3.3 in 
fertilized mouse zygotes results in growth arrest at the mor-
ula stage (Lin et al., 2013). H3.3-deficient embryos display 
significantly reduced levels of open chromatin markers 
(such as H3K36me2 and H4K16Ac) and increased incorpo-
ration of linker H1, resulting in over-condensation and 
mis-segregation of chromosomes (Lin et al., 2013). Togeth-
er, these findings indicate that H3.3 is involved in estab-
lishing a finely balanced equilibrium between open and 
condensed chromatin states during early mouse develop-
ment. Knockout of HIRA in mice was embryonically lethal, 
with defects in early gastrulation and disruption in meso-
dermal development (Roberts et al., 2002); this phenotype 
was similar to that observed for H3.3-deficient embryo   
in Xenopus (Szenker et al., 2012). Moreover, DAXX and 
ATRX knockout mice died before E9.5 (Garrick et al.,  
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Figure 2  Roles of H3.3 and its chaperones during mammalian development and human cancers. A, H3.3 and its chaperones take part in several 
development stages during the life cycle of mammal, such as fertilization, early embryo development, PGCs reprogramming and gametogenesis. B, H3.3 
mutations in skeletal and brain tissues. K36M and G34W/L mutants are prevalent in a variety of bone tumors and result in the decrease of H3K36me3. The 
K27M and G34V/R mutants are present in the gliomas. K27M mutation containing nucleosomes bind PRC2 with high affinity and inhibit PRC2 activity, 
thus leading to a global loss of H3K27me3. The G34V/R mutation containing nucleosomes also inhibit H3K36me3 in the tumor cells. 
2006; Michaelson et al., 1999). Thus, these H3.3 chaper-
ones are essential for early embryo development, but 
whether these phenotypes of chaperone knockout mice are 
specifically linked to H3.3 requires further investigation.  
The function of H3.3 in gametogenesis 
Drosophila with null mutations in both H3.3 genes survive 
to adulthood; however, both females and males are sterile, 
with chromosome condensation and segregation of germ- 
lines defective (Sakai et al., 2009). In mice, H3f3a-null 
males are subfertile, and H3f3b heterozygotes-null males 
are sterile (Tang et al., 2015). These phenotypes in both 
mice and Drosophila suggest that H3.3 is critical for fertili-
ty. H3.3 is expressed throughout the mouse seminiferous 
tubule, and depletion of H3f3b resulted in male testes atro-
phy, abnormal sperm morphology, and was also shown to 
disrupt the expression patterns of spermatogenesis-related 
genes (Yuen et al., 2014). In mammalian males, the X and 
Y chromosomes are transcriptionally silenced during the 
meiosis of spermatogenesis, a process called meiotic 
sex-chromosome inactivation (MSCI). H3.3 was specifical-
ly incorporated into the XY chromosome during the MSCI 
process (van der Heijden et al., 2007). During spermato-
genesis, the male germ cells undergo an extensive chroma-
tin remodeling process: histones are largely exchanged for 
protamine and protamine-like proteins, resulting in the for-
mation of highly condensed chromatin. However, not all 
nucleosomes were replaced, with a small number of H3.3- 
containing nucleosomes being retained. These nucleosomes 
are enriched in all those genomic regions that are important 
for development (Yuen et al., 2014). In mouse sperm, H3.3 
is enriched at high-CpG rich promoters that are not methyl-
ated (Erkek et al., 2013). H3.3 was also found to be essen-
tial during folliculogenesis and primary oocytes develop-
ment (Tang et al., 2015). Furthermore, a mutation in ye-
manuclein (yem), the homolog of UBN1 subunit of HIRA 
complex in Drosophila, was found to affect chromosome 
segregation in the first oocyte meiotic division (Meyer    
et al., 2010). Taken together, these findings reveal that H3.3 
affects the meiosis of germ cells and plays an important role 
in the gametogenesis. Furthermore, HIRA protein was en-
riched in the nucleus in mouse primordial germ cells 
(PGCs) undergoing reprogramming (Hajkova et al., 2008). 
As an H3.3-specific antibody remains unavailable due to the 
minor sequence difference to canonical H3, it is still not 
known whether H3.3 is also enriched in PGCs nuclei. Thus, 
the H3f3b-HA knock-in mouse will be a long-awaited mod-
el system that should provide exciting insights into the 
function of H3.3 in PGCs.  
The function of H3.3 in fertilization  
During the late haploid phase of spermatogenesis, the ma-
jority of the histone in sperm chromatin is replaced by pro-
tamine, resulting in sperm head condensation. Following 
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fertilization, this process is reversed, and new maternal 
H3.3 is preferentially incorporated into the paternal pronu-
cleus (PN), replacing protamine and altering chromatin or-
ganization (Akiyama et al., 2011). It has been shown for 
both Drosophila and mice that the deposition of H3.3 on 
paternal pronucleus is dependent on the presence of the 
HIRA complex (Inoue and Zhang, 2014; Loppin et al., 
2005). Similarly, in HIRA mutant mouse zygotes, nucleo-
somes cannot assemble at the paternal pronucleus, and as a 
consequence , both parental genomes show deficiencies in 
DNA replication as well as rRNA transcription (Inoue and 
Zhang, 2014; Lin et al., 2014). These results show that 
HIRA-mediated H3.3 deposition is important for repro-
gramming of the parental genome during fertilization. In 
addition, H3.3 is specifically enriched in the paternal peri-
centromeric chromatin, and is essential for the establish-
ment of pericentromeric heterochromatin in the mouse em-
bryo. Mutation of H3.3 K27, but not of H3.1 K27, results in 
de-repression of pericentromeric transcripts, HP1 mis- 
localization, dysfunctional chromosome segregation and 
developmental arrest (Santenard et al., 2010). In paternal 
pronucleus (PN), overexpression of a H3.3 K4M mutant 
before fertilization causes a significant reduction in global 
H3K4me3, decreasing the level of minor zygotic gene acti-
vation (ZGA) in PN, and as a consequence, reducing the 
survival rate of the embryo (Aoshima et al., 2015). Togeth-
er, these studies suggest that H3.3 affects embryo develop-
ment after fertilization through specific post-translation 
modification of its N-terminal tail.  
The function of H3.3 in the epigenetic reprogramming 
during somatic cell nuclear transfer 
During SCNT (somatic cell nuclear transfer), the donor nu-
cleus proteins are exchanged by the oocyte proteins, result-
ing in extensive remodeling of the donor chromatin and the 
reactivation of pluripotency genes such as Sox2, Oct4, 
Nanog (Gurdon and Wilmut, 2011). The cytoplasm of ma-
ture mouse oocytes contains abundant amounts of both 
H3f3a and H3f3b mRNAs; however, these maternal tran-
scripts are largely degraded at the first embryonic cleavage 
(20 h after oocyte activation), whereas zygotic H3.3 mRNA 
increases after the two-cell stage (Wen et al., 2014a).  
H3.3 takes part in both the transition of epigenetic 
memory and the transcriptional reprogramming of donor 
nuclei. On one hand, H3.3 is incorporated into transcrip-
tionally active regions of the donor cell, thus maintaining 
gene expression patterns after nuclear transfer. For example, 
the transferred embryos can remember the expression of 
MyoD with the incorporation of H3.3 at the MyoD promoter 
in Xenopus, and the H3.3 K4 mutant eliminates this 
memory (Ng and Gurdon, 2008). On the other hand, H3.3 is 
required for the reactivation of key pluripotency genes of 
the donor nucleus. It has been shown that exogenous H3.3 
deposits at not only the regulatory regions of Oct4, but also 
other genomic regions, including the major satellite repeats 
and rDNA (Jullien et al., 2012). In addition, knockdown of 
maternal H3.3 results in compromised reprogramming and 
failure to reactivate key pluripotency genes, such as Oct4 in 
mouse embryos (Wen et al., 2014a). These results indicated 
that H3.3 is required for epigenetic reprogramming and em-
bryonic development of SCNT embryos. 
The function of H3.3 in cell differentiation 
Pluripotent embryonic stem cells possess the capacity for 
self-renewal and the potential to differentiate into multiple 
lineages. The differentiation potential of ES cells is estab-
lished by marking lineage-specific genes prior to their ex-
pression. In ES cells, the promoters of lineage-specific 
genes are simultaneously marked by both activation-   
associated H3K4me3 and repression-associated H3K27me3 
modifications. These regions are referred to as “bivalent 
domains”, and these bivalent genes are poised for activation 
during differentiation. A recent study reported that H3.3 is 
enriched at these bivalent domains in mouse ES cells 
(Goldberg et al., 2010). When the ES cells differentiated to 
neuronal precursor cells (NPCs), the genome-wide distribu-
tion patterns of H3.3 were changed. For the bivalent genes 
activated in NPCs, H3.3 is maintained at the TSS and also 
incorporated into the gene body. In contrast, for the re-
maining repressed bivalent genes in NPCs, the H3.3 deposi-
tion is decreased around the TSS sites (Goldberg et al., 
2010). Furthermore, in H3.3 knockdown ES cells, the ex-
pression patterns of bivalent genes and the developmental 
potential ability was changed during the differentiation 
process. Therefore, H3.3 appears to be essential for ES cell 
differentiation, but the underlying molecular mechanisms 
remain to be elucidated. 
Further studies indicate that H3.3 plays an important role 
in the maintenance of specific chromatin states achieved 
through an interaction with Polycomb repressive complex 2 
(PRC2). PRC2 regulates gene expression through histone 
H3 lysine 27 trimethylation (H3K27me3). In mouse ESCs, 
H3.3 incorporation at bivalent regions facilitates the re-
cruitment of PRC2 to ensure the establishment of H3K27- 
me3 marks. Upon H3.3 depletion, the levels of H3K27me3 
were found to be reduced at these promoters, but the levels 
of H3K4me3 remained unchanged (Banaszynski et al., 
2013). In Drosophila, H3.3 was also found to be enriched at 
PRC2 binding regions (Mito et al., 2007). These findings 
strongly suggest that H3.3 facilitates a type of specific 
chromatin state for PRC2 binding at bivalent domains. 
Using a murine C2C12 differentiation system, it is re-
ported that H3.3 is also deposited at the bivalent domains of 
skeletal muscle gene (SKM) prior to the differentiation by 
chromodomain helicase DNA-binding domain 2 (Chd2) 
(Harada et al., 2012). In addition, H3.3 also localizes at the 
transcriptional regulatory regions of MyoD gene mediated 
by HIRA (Yang et al., 2011). Knockdown of Chd2 or H3.3 
decreases the incorporation of H3.3 into the SKM gene loci, 
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and reduces the levels of H3K27me3 and H3K4me3 at 
SKM bivalent domains, resulting in myogenic differentia-
tion impairment. Therefore, H3.3 may be essential not only 
for gene transcription, but may also be important for estab-
lishing bivalent domains required for reliable and fast 
switching on or off the expression of genes during differen-
tiation.  
H3.3 AND DISEASE 
H3.3 participates in the regulation of chromatin structure 
and is involved in the maintenance of specific chromatin 
states, which are important for transcriptional regulation 
during development. Recently, the function of H3.3 has 
been highlighted by recurrent somatic mutations identified 
in gliomas and a subset of skeletal neoplasms. These muta-
tions include K27M, G34R/W/V/L, and K36M in both 
H3F3A and H3F3B genes (Figure 2B) (Behjati et al., 2013; 
Schwartzentruber et al., 2012; Sturm et al., 2012; Wu et al., 
2012) . 
Pediatric high-grade gliomas (pHGGs), including glio-
blastomas (GBM) and diffuse intrinsic pontine gliomas 
(DIPGs) are highly aggressive brain tumors with leading 
mortality and morbidity in children. In recent efforts to un-
derstand their molecular pathogenesis, two recurrent somat-
ic H3F3A mutations resulting in amino acid substitutions 
(K27M and G34R/V) were found almost exclusively in pe-
diatric GBM and DIPGs by whole genome exon sequencing 
(Schwartzentruber et al., 2012; Sturm et al., 2012; Wu et al., 
2012). In the DIPG group, K27M mutation occurred in the 
entire H3 family, with a high preference of H3F3A (60%) 
over HIST1H3B (18%), and the mutation of these two H3 
isoforms was found to be mutually exclusive. While no 
G34R/V mutation was identified in the DIPG samples, 14% 
of the GBM samples harbor G34R or K27M mutations in 
H3F3A and HIST1H3B. In another population study, H3.3 
mutation was also found to be highly specific for GBM 
samples, and the prevalence was significantly higher in the 
pediatric group than the young adult group (Schwartzen- 
truber et al., 2012). K27M and G34R/V mutations of 
H3F3A were found in these samples with an almost equal 
mutation rate; however, they displayed specific temporal 
and spatial distributions. The K27M was more prevalent in 
younger children and G34R/V in a relative older group. The 
spatial distribution difference within the central nervous 
system was that K27M located in tumors along the middle 
line location, including spinal cord, thalamus, pons, and 
brainstem; while G34R/V located in the cerebral hemi-
sphere (Figure 2B). While there are two genes—H3F3A and 
H3F3B coding the same H3.3 protein in human genome, 
these mutations have not been detected in H3F3B gene so 
far, indicating that the origin of these somatic mutations 
may be related to the unique mRNA-untranslated region or 
regulatory element of the H3F3A gene (Albig et al., 1995; 
Witt et al., 1997). Furthermore, in all tumor samples tested, 
only one allele of H3F3A gene was found mutated for both 
K27M and G34R/V substitutions, and they occurred in a 
mutually exclusive fashion. Together, these data indicate 
that K27M mutation and G34R/V may originate via differ-
ent pathways, related to specific clone precursors, genesis 
niche and develop stage (Yuen and Knoepfler, 2013).  
The mutation spectrum of H3.3 was found extended to 
K36M and G34W/L in a variety of bone and cartilage tu-
mors. This spectrum also showed tumor type-specific H3.3 
mutations (Behjati et al., 2013). While the K36M substitu-
tion was found predominantly in H3F3B gene in chondro-
blastoma, G34W/L mutation exclusively existed in H3F3A 
gene. In rare cases, H3F3A p.K36M and H3F3B p.K36M 
mutations occurred in conventional chondrosarcoma and 
clear-cell chondrosarcoma, respectively. In osteosarcoma, a 
G34R substitution was found in both H3F3A and H3F3B 
genes. 
Other somatic mutations have been found simultaneously 
with H3.3 mutations in pHGGs, including mutations in 
TP53 (Khuong-Quang et al., 2012; Schwartzentruber et al., 
2012), ATRX (Fontebasso et al., 2014; the St. Jude Chil- 
dren’s Research Hospital-Washington University Pediatric 
Cancer Genome, 2014), DAXX (Khuong-Quang et al., 2012; 
Schwartzentruber et al., 2012), NF1 (Schwar- tzentruber  
et al., 2012), PDGFRA (Paugh et al., 2013), ACVR1 (Bucz- 
kowicz et al., 2014; Fontebasso et al., 2014; Taylor et al., 
2014; the St. Jude Children’s Research Hospital-Wash- 
ington University Pediatric Cancer Genome, 2014) and 
SETD2 (Wu et al., 2014). While TP53 mutation was found 
in half of all sequenced GBM samples, it showed no pref-
erential co-occurrence with K27M or G34R/V, similar to 
the NF1 mutation and PDGFRA mutation. Although 
ATRX/DAXX mutations overlapped with H3.3 K27M muta-
tions, this correlation was not found to be statistically sig-
nificant. Surprisingly, all samples with the G34R/V muta-
tion and ATRX/DAXX mutation also co-existed with a TP53 
mutation (Schwartzentruber et al., 2012). Although somatic 
mutations of ATRX/DAXX have been reported in a large 
proportion of pancreatic neuroendocrine tumors (PanNETs), 
no TP53 or H3F3A mutation was found to co-exist. Fur-
thermore, these mutations were associated with better 
prognosis clinically. Mutations of ACVR1 were found in 
pediatric midline high-grade astrocytomas (mHGAs) con-
taining a K27M mutation. Such a situation results in lig-
and-independent activation of the kinase, which further re-
sults in enhanced BMP (bone morphogenetic protein) sig-
naling. Interestingly, these mutations of ACVR1 were linked 
to the presence of a HIST1H3B mutation (H3.1 K27M) and 
were associated with a younger age of onset of disease. In-
activating mutations of the histone H3 K36 trimethyltrans-
ferase-SETD2 were found in a subgroup of pediatric HGG 
bearing H3.1K27M substitution. These mutations may in-
teract with H3.3 mutation and provide selective advantages 
for glioma genesis. 
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H3.3K27M and tumorigenesis  
The N-terminal tail of H3 is positioned outside of the nu-
cleosome, and contains several positively charged residues, 
including lysine 4, lysine 9, lysine 27, and lysine 36 as in-
dicated in Figure 1A. These residues can be both methylated 
or acetylated, and play important roles in the regulation of 
chromatin structure and transcriptional activity during nor-
mal development and tumorigenesis. H3K27 can be meth-
ylated specifically by PRC2, producing either H3K27me2 
or H3K27me3. H3K27me3 can recruit Polycomb repressive 
complex (PRC1), which catalyzes ubiquitination on H2A 
K119. Interestingly, the modification H2AK119ub can, in 
turn, recruit PRC2, thus, forming a positive feedback to 
maintain a repressive chromatin state. This repressive 
memory is involved in the body planning during the devel-
opment of Drosophila and X chromosome inactivation in 
mammals.  
Therefore, the question remains of what the consequence 
is of the K27M mutation in the pHGGS? In the DIPG and 
pHGGs patient samples bearing H3.3 K27M mutation or 
H3.1K27M mutation, global levels of both H3K27me2 and 
H3K27me3 were dramatically reduced, while H3K27ac 
levels increased mildly, albeit only one allele was mutated 
and expressed among all the H3 isoforms. EZH2 expression 
was high in GBMs, but absent in other tumors. However, no 
significant differences in EZH2 expression were observed 
between H3F3A K27M mutant and wild type GBMs 
(Bender et al., 2013; Chan et al., 2013; Lewis et al., 2013). 
Moreover, this phenomenon can be recaptured by introduc-
ing an H3.3K27M or H3.1K27M mutation in cultured cell 
lines with no effect on the protein levels of all the PRC2 
core subunits. In both tumor samples and transformed cell 
lines, K27M mutation do not have any effect on other his-
tone modifications, such as H3K27me1, H3K4me3, H3K9- 
me3, H3K9Ac, H3K36me3 (Chan et al., 2013; Lewis et al., 
2013). However, in DIPG samples containing H3.3G34R/V 
or H3.1G34R/V mutations, the global level of H3K27me2 
and H3K27me3 did not change. These results argued that 
the global change of H3K27me2/3 was specific to K27M 
mutation. These results also suggest that the K27M muta-
tion, either on H3.3 or H3.1, represses H3K27 methylation 
activity of PRC2 toward wild type H3 histones in-trans. It is 
to note that H3K27M peptide directly binds EZH2 with 
high affinity. Similarly, using immunoprecipitation, EZH2 
and EED were found enriched on H3.3K27M mutant nu-
cleosomes, not, however, on the wild-typecounterpart. Us-
ing an in vitro histone methyltransferase (HMT) assay, it 
was found that both nucleosomes containing H3K27M and 
H3K27M peptide greatly inhibit PRC2 activity (Lewis et al., 
2013). Taken together, these data suggest that K27M con-
taining nucleosomes bind the catalytic subunit of PRC2 as a 
mutated substrate with high affinity to inhibit the methyl-
transferase activity of PRC2. This results in a global loss of 
H3K27me2 and H3K27me3 modification in pHGGs. 
PRC2 and H3K27me3 have been reported to regulate 
transcriptional activity of genes, and were important for the 
maintenance of stem cell identity and normal development 
across diverse organisms. Disruptions of the PRC2- 
H3K27me3 pathway have been found in many tumors, and 
contribute to tumorigenesis dependent on differing cellular 
contexts (Hock, 2012). Using ChIP-seq, it was found that 
more than three quarters of the H3K27me3 peaks were lost 
across genic and intergenic regions without chromatin con-
text specificity (Bender et al., 2013; Chan et al., 2013). 
However, the effect of K27M mutation on the alternation of 
H3K27me3 is more complicated in specific genomic re-
gions. In contrast with the dramatic change of H3K27me3, 
both EZH2 and H3K4me3 showed almost no change across 
the genome (Chan et al., 2013). The neural transcription 
factor OLIG2 has been reported to repress the p53-signaling 
pathway and promote tumorigenesis of malignant glioma 
(Mehta et al., 2011). Interestingly, its up-regulation in DIPG 
correlated with a decrease in H3K27me3 and increase in 
H3K4me3 in its promoter region. Other cancer-associated 
genes such as p16INK4A and CDK6 were repressed with 
increased H3K27me3 in the promoter regions in DIPG. 
Moreover, in pHGGs samples, DNA methylation also 
showed genome-wide changes, with more hypo-methylated 
regions than hyper-methylated regions detected. This reality 
contributed to the dysregulation of the cancer transcriptome 
(Bender et al., 2013). However, in DIPGs harboring no 
K27M mutation, H3K27me3 level was found to be normal 
(Lewis et al., 2013), suggesting that other oncogenesis 
pathways exist in pHGGs. 
H3.3K36M and tumorigenesis 
H3K36me3, the product of methyltransferase SETD2, is 
found throughout actively transcribed regions, and is posi-
tively correlated with transcriptional activity. H3K36me3 
and SETD2 have been demonstrated to regulate both tran-
scriptional elongation and alternative splicing events 
(Wagner and Carpenter, 2012). Several proteins have been 
reported to read H3K36me3 modifications by virtue of pos-
sessing a PWWP domain, including DNMT3a and Brpf1 
(Dhayalan et al., 2010; Vezzoli et al., 2010; Wu et al., 
2011). A recent report described for the first time, a reader 
for H3.3-specific K36me3 called BS69/ZMYND11 (Wen  
et al., 2014c). BS69 has been identified as a tumor suppres-
sor, as it inhibits transcriptional activation regulated by E1A 
and c-Myb (Hateboer et al., 1995; Ladendorff et al., 2001). 
H3K36me3 of H3.3 recruits BS96 to the elongation region 
of specific genes to regulate RNA alternative splicing via 
interaction with RNA splicing regulators (Guo et al., 2014). 
In another study, BS69/ZMYND11 was reported to regulate 
transcription elongation via its recognition of H3K36me3 
on H3.3. Thus it repressed transcriptional programs essen-
tial for tumor proliferation (Wen et al., 2014c). 
The K36M mutation has been found in H3F3B at high 
prevalence in Chondroblastoma, and was reported to abolish 
H3K36me3 modification when introduced in 293T cells. In 
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DIPG samples containing H3.3G34R/V or H3.1G34R/V 
mutations, global levels of histone modifications remain 
unchanged, including H3K36me3. However, using im-
munoprecipitation, a marked loss of H3K36me3 on G34R/V 
mutations containing-nucleosomes can be observed. This 
result indicates that H3K36me3 is regulated indirectly 
through Gly34, possibly because it is involved in the re-
cruitment of methyltransferase. Surprisingly, in pediatric 
GBM tumors, H3K36me3 and Pol II were found aberrantly 
enriched within genic regions of several key transcription 
factors, including MYCN, Sox2 and DLX6, which may be 
involved in the elevated transcription of these genes, thus 
resulting in the reprogramming of the transcriptional states 
of the tumor towards an earlier developmental stage (Bjerke 
et al., 2013). Taken together, H3.3 mutations can promote 
pHGGs tumorigenesis via a hijacking H3K36me3 pathway 
either directly (K36M mutation) or indirectly (G34R/V/W/L 
mutations), thus functioning within a specific tissue envi-
ronment. As discussed above, the epigenetic information of 
H3K36me3 can be decoded by various readers; thus, these 
readers will act in a misguided manner upon pathological 
changes in H3K36me3 patterns.  
Although there is no evidence that Lys27 and Gly34 res-
idue can regulate the genome-wide deposition of H3.3, it 
still needs to be determined whether these mutations direct-
ly impact the interaction between H3.3 histones and their 
dedicated chaperone complexes, and whether these muta-
tions cause a mis-deposition of H3.3 along the cancer ge-
nome. 
CONCLUSIONS 
H3.3 is an important histone variant that is deposited into 
the specific loci of chromatin by dedicated chaperones to 
regulate the various cellular activities. H3.3 can be incorpo-
rated into both the euchromatin and heterochromatin by 
different chaperones. The HIRA complex mediates the dis-
tribution of H3.3 at transcription start sites and gene bodies 
of transcribed genes. DAXX/ATRX mediates the incorpora-
tion of H3.3 into heterochromatin sites, such as telomeres, 
pericentromeres and repetitive elements. This diverse dis-
tribution suggests that H3.3 not only takes part in transcrip-
tional regulation, but also in the establishment and mainte-
nance of the heterochromatin state. Therefore, H3.3 has 
different functions at different chromatin environments. In 
addition, H3.3 is deposited at specific intergenic regions 
independent of HIRA and DAXX, with an unknown deposi-
tion pathway (Figure 1B). H3.3 is retained in the sperm 
chromatin during spermatogenesis, which raises the ques-
tion as to whether there is a testis-specific H3.3 chaperone. 
As ChIP-seq technology advances, it will be possible to 
obtain finer and more comprehensive maps of H3.3 across 
the genome at detailed spatial and temporal resolution, both 
during development and in specific tissues. 
Recent studies showed convincingly that H3.3 is im-
portant for development, whereas mutated H3.3 forms are 
implicated in tumorigenesis. Whether H3.3 regulates these 
processes directly by influencing the chromatin structure or 
indirectly through other mechanisms, however, remains 
unknown. The somatic mutations of H3.3 were recently 
reported in a number of malign tumors, such as glioblasto-
mas and skeletal neoplasms. The relationship between these 
mutants and tumorigenesis is under intensive research. 
Apart from the PRC2-H3K27me3 and H3K36me3 pathways 
studied recently, there are other potential mechanisms. 
ATRX/DAXX meditates the H3.3 deposition in telomeres 
in ES cells to maintain the integrity of chromatin. The 
co-existence of ATRX and DAXX mutations with H3.3 mu-
tant hinted that the ATRX/DAXX/H3.3 axis disruption may 
cause the instability of the telomere and facilitate tumor-
igenesis. If this is true, the ATRX/DAXX/H3.3 axis may 
provide a new therapeutic target for gliomas and other tu-
mors.  
Compliance and ethics  The author(s) declare that they have no conflict 
of interest. 
Acknowledgements  This work was supported by the National Natural 
Science Foundation of China (91219202) to Guohong Li., the Ministry of 
Science and Technology of China (2015CB856200, 2011CB966300), the 
Chinese Academy of Sciences (CAS) Strategic Priority Research Program 
(XDA01010304) and the National Natural Science Foundation of China 
(31301047) to Chaoyang Xiong. 
Adam, S., Polo, S.E., and Almouzni, G. (2013). Transcription recovery 
after DNA damage requires chromatin priming by the H3.3 histone 
chaperone HIRA. Cell 155, 94–106. 
Ahmad, K., and Henikoff, S. (2002). The histone variant H3.3 marks active 
chromatin by replication-independent nucleosome assembly. Mol Cell  
9, 1191–1200. 
Akiyama, T., Suzuki, O., Matsuda, J., and Aoki, F. (2011). Dynamic 
replacement of histone H3 variants reprograms epigenetic marks in 
early mouse embryos. PLoS Genet 7, e1002279. 
Albig, W., Bramlage, B., Gruber, K., Klobeck, H.G., Kunz, J., and 
Doenecke, D. (1995). The human replacement histone H3.3B gene 
(H3F3B). Genomics 30, 264–272. 
Aoshima, K., Inoue, E., Sawa, H., and Okada, Y. (2015). Paternal H3K4 
methylation is required for minor zygotic gene activation and early 
mouse embryonic development. EMBO Rep 16, 803–812. 
Banaszynski, L.A., Wen, D., Dewell, S., Whitcomb, S.J., Lin, M., Diaz, N., 
Elsasser, S.J., Chapgier, A., Goldberg, A.D., Canaani, E., Rafii, S., 
Zheng, D., and Allis, C.D. (2013). Hira-dependent histone H3.3 
deposition facilitates PRC2 recruitment at developmental loci in ES 
cells. Cell 155, 107–120. 
Behjati, S., Tarpey, P.S., Presneau, N., Scheipl, S., Pillay, N., Van Loo, P., 
Wedge, D.C., Cooke, S.L., Gundem, G., Davies, H., Nik-Zainal, S., 
Martin, S., McLaren, S., Goody, V., Robinson, B., Butler, A., Teague, 
J.W., Halai, D., Khatri, B., Myklebost, O., Baumhoer, D., Jundt, G., 
Hamoudi, R., Tirabosco, R., Amary, M.F., Futreal, P.A., Stratton, M.R., 
Campbell, P.J., and Flanagan, A.M. (2013). Distinct H3F3A and 
H3F3B driver mutations define chondroblastoma and giant cell tumor 
of bone. Nat Genet 45, 1479–1482. 
Bender, S., Tang, Y., Lindroth, A.M., Hovestadt, V., Jones, D.T., Kool, 
M., Zapatka, M., Northcott, P.A., Sturm, D., Wang, W., Radlwimmer, 
B., Hojfeldt, J.W., Truffaux, N., Castel, D., Schubert, S., Ryzhova, M., 
Seker-Cin, H., Gronych, J., Johann, P.D., Stark, S., Meyer, J., Milde, 
T., Schuhmann, M., Ebinger, M., Monoranu, C.M., Ponnuswami, A., 
254 Xiong, C., et al.   Sci China Life Sci   March (2016) Vol.59 No.3 
Chen, S., Jones, C., Witt, O., Collins, V.P., von Deimling, A., Jabado, 
N., Puget, S., Grill, J., Helin, K., Korshunov, A., Lichter, P., Monje, 
M., Plass, C., Cho, Y.J., and Pfister, S.M. (2013). Reduced H3K27me3 
and DNA hypomethylation are major drivers of gene expression in 
K27M mutant pediatric high-grade gliomas. Cancer Cell 24, 660–672. 
Bjerke, L., Mackay, A., Nandhabalan, M., Burford, A., Jury, A., Popov, S., 
Bax, D.A., Carvalho, D., Taylor, K.R., Vinci, M., Bajrami, I., 
McGonnell, I.M., Lord, C.J., Reis, R.M., Hargrave, D., Ashworth, A., 
Workman, P., and Jones, C. (2013). Histone H3.3. mutations drive 
pediatric glioblastoma through upregulation of MYCN. Cancer Discov 
3, 512–519. 
Buczkowicz, P., Hoeman, C., Rakopoulos, P., Pajovic, S., Letourneau, L., 
Dzamba, M., Morrison, A., Lewis, P., Bouffet, E., Bartels, U., Zuccaro, 
J., Agnihotri, S., Ryall, S., Barszczyk, M., Chornenkyy, Y., Bourgey, 
M., Bourque, G., Montpetit, A., Cordero, F., Castelo-Branco, P., 
Mangerel, J., Tabori, U., Ho, K.C., Huang, A., Taylor, K.R., Mackay, 
A., Bendel, A.E., Nazarian, J., Fangusaro, J.R., Karajannis, M.A., 
Zagzag, D., Foreman, N.K., Donson, A., Hegert, J.V., Smith, A., Chan, 
J., Lafay-Cousin, L., Dunn, S., Hukin, J., Dunham, C., Scheinemann, 
K., Michaud, J., Zelcer, S., Ramsay, D., Cain, J., Brennan, C., 
Souweidane, M.M., Jones, C., Allis, C.D., Brudno, M., Becher, O., and 
Hawkins, C. (2014). Genomic analysis of diffuse intrinsic pontine 
gliomas identifies three molecular subgroups and recurrent activating 
ACVR1 mutations. Nat Genet 46, 451–456. 
Bush, K.M., Yuen, B.T., Barrilleaux, B.L., Riggs, J.W., O’Geen, H., 
Cotterman, R.F., and Knoepfler, P.S. (2013). Endogenous mammalian 
histone H3.3 exhibits chromatin-related functions during development. 
Epigenet Chromat 6, 7. 
Chan, K.-M., Fang, D., Gan, H., Hashizume, R., Yu, C., Schroeder, M., 
Gupta, N., Mueller, S., James, C.D., Jenkins, R., Sarkaria, J., and 
Zhang, Z. (2013). The histone H3.3K27M mutation in pediatric glioma 
reprograms H3K27 methylation and gene expression. Genes Dev 27, 
985–990. 
Chen, P., Zhao, J., Wang, Y., Wang, M., Long, H., Liang, D., Huang, L., 
Wen, Z., Li, W., Li, X., Feng, H., Zhao, H., Zhu, P., Li, M., Wang, 
Q.F., and Li, G. (2013). H3.3 actively marks enhancers and primes 
gene transcription via opening higher-ordered chromatin. Genes Dev 
27, 2109–2124. 
Deal, R.B., Henikoff, J.G., and Henikoff, S. (2010). Genome-wide kinetics 
of nucleosome turnover determined by metabolic labeling of histones. 
Science 328, 1161–1164. 
Dhayalan, A., Rajavelu, A., Rathert, P., Tamas, R., Jurkowska, R.Z., 
Ragozin, S., and Jeltsch, A. (2010). The Dnmt3a PWWP domain reads 
histone 3 lysine 36 trimethylation and guides DNA methylation. J Biol 
Chem 285, 26114–26120. 
Elsasser, S.J., Noh, K.M., Diaz, N., Allis, C.D., and Banaszynski, L.A. 
(2015). Histone H3.3 is required for endogenous retroviral element 
silencing in embryonic stem cells. Nature 522, 240–244. 
Erkek, S., Hisano, M., Liang, C.Y., Gill, M., Murr, R., Dieker, J., 
Schubeler, D., van der Vlag, J., Stadler, M.B., and Peters, A.H. (2013). 
Molecular determinants of nucleosome retention at CpG-rich sequences 
in mouse spermatozoa. Nat Struct Mol Biol 20, 868–875. 
Filipescu, D., Szenker, E., and Almouzni, G. (2013). Developmental roles 
of histone H3 variants and their chaperones. Trends Genet 29, 630–640. 
Fontebasso, A.M., Papillon-Cavanagh, S., Schwartzentruber, J., Nikbakht, 
H., Gerges, N., Fiset, P.O., Bechet, D., Faury, D., De Jay, N., 
Ramkissoon, L.A., Corcoran, A., Jones, D.T., Sturm, D., Johann, P., 
Tomita, T., Goldman, S., Nagib, M., Bendel, A., Goumnerova, L., 
Bowers, D.C., Leonard, J.R., Rubin, J.B., Alden, T., Browd, S., Geyer, 
J.R., Leary, S., Jallo, G., Cohen, K., Gupta, N., Prados, M.D., Carret, 
A.S., Ellezam, B., Crevier, L., Klekner, A., Bognar, L., Hauser, P., 
Garami, M., Myseros, J., Dong, Z., Siegel, P.M., Malkin, H., Ligon, 
A.H., Albrecht, S., Pfister, S.M., Ligon, K.L., Majewski, J., Jabado, N., 
and Kieran, M.W. (2014). Recurrent somatic mutations in ACVR1 in 
pediatric midline high-grade astrocytoma. Nat Genet 46, 462–466. 
Frank, D., Doenecke, D., and Albig, W. (2003). Differential expression of 
human replacement and cell cycle dependent H3 histone genes. Gene 
312, 135–143. 
Garrick, D., Sharpe, J.A., Arkell, R., Dobbie, L., Smith, A.J., Wood, W.G., 
Higgs, D.R., and Gibbons, R.J. (2006). Loss of Atrx affects trophoblast 
development and the pattern of X-inactivation in extraembryonic 
tissues. PLoS Genet 2, e58. 
Goldberg, A.D., Banaszynski, L.A., Noh, K.M., Lewis, P.W., Elsaesser, 
S.J., Stadler, S., Dewell, S., Law, M., Guo, X., Li, X., Wen, D., 
Chapgier, A., DeKelver, R.C., Miller, J.C., Lee, Y.L., Boydston, E.A., 
Holmes, M.C., Gregory, P.D., Greally, J.M., Rafii, S., Yang, C., 
Scambler, P.J., Garrick, D., Gibbons, R.J., Higgs, D.R., Cristea, I.M., 
Urnov, F.D., Zheng, D., and Allis, C.D. (2010). Distinct factors control 
histone variant H3.3 localization at specific genomic regions. Cell 140, 
678–691. 
Guo, R., Zheng, L., Park, J.W., Lv, R., Chen, H., Jiao, F., Xu, W., Mu, S., 
Wen, H., Qiu, J., Wang, Z., Yang, P., Wu, F., Hui, J., Fu, X., Shi, X., 
Shi, Y.G., Xing, Y., Lan, F., and Shi, Y. (2014). BS69/ZMYND11 
reads and connects histone H3.3 lysine 36 trimethylation-decorated 
chromatin to regulated pre-mRNA processing. Mol Cell 56, 298–310. 
Gurdon, J.B., and Wilmut, I. (2011). Nuclear transfer to eggs and oocytes. 
Cold Spring Harb Perspect Biol 3. 
Hajkova, P., Ancelin, K., Waldmann, T., Lacoste, N., Lange, U.C., Cesari, 
F., Lee, C., Almouzni, G., Schneider, R., and Surani, M.A. (2008). 
Chromatin dynamics during epigenetic reprogramming in the mouse 
germ line. Nature 452, 877–881. 
Hake, S.B., Garcia, B.A., Kauer, M., Baker, S.P., Shabanowitz, J., Hunt, 
D.F., and Allis, C.D. (2005). Serine 31 phosphorylation of histone 
variant H3.3 is specific to regions bordering centromeres in metaphase 
chromosomes. Proc Natl Acad Sci USA 102, 6344–6349. 
Hamiche, A., and Shuaib, M. (2013). Chaperoning the histone H3 family. 
Biochim Biophys Acta 1819, 230–237. 
Harada, A., Okada, S., Konno, D., Odawara, J., Yoshimi, T., Yoshimura, 
S., Kumamaru, H., Saiwai, H., Tsubota, T., Kurumizaka, H., Akashi, 
K., Tachibana, T., Imbalzano, A.N., and Ohkawa, Y. (2012). Chd2 
interacts with H3.3 to determine myogenic cell fate. EMBO J 31, 
2994–3007. 
Hateboer, G., Gennissen, A., Ramos, Y.F., Kerkhoven, R.M., 
Sonntag-Buck, V., Stunnenberg, H.G., and Bernards, R. (1995). BS69, 
a novel adenovirus E1A-associated protein that inhibits E1A 
transactivation. Embo J 14, 3159–3169. 
Henikoff, S., and Ahmad, K. (2005). Assembly of variant histones into 
chromatin. Annu Rev Cell Dev Biol 21, 133–153. 
Henikoff, S., Henikoff, J.G., Sakai, A., Loeb, G.B., and Ahmad, K. (2009). 
Genome-wide profiling of salt fractions maps physical properties of 
chromatin. Genome Res 19, 460–469. 
Hock, H. (2012). A complex Polycomb issue: the two faces of EZH2 in 
cancer. Genes Dev 26, 751–755. 
Huang, C., Zhang, Z., Xu, M., Li, Y., Li, Z., Ma, Y., Cai, T., and Zhu, B. 
(2013). H3.3-H4 tetramer splitting events feature cell-type specific 
enhancers. PLoS Genet 9, e1003558. 
Inoue, A., and Zhang, Y. (2014). Nucleosome assembly is required for 
nuclear pore complex assembly in mouse zygotes. Nat Struct Mol Biol 
21, 609–616. 
Jin, C., Zang, C., Wei, G., Cui, K., Peng, W., Zhao, K., and Felsenfeld, G. 
(2009). H3.3/H2A.Z double variant-containing nucleosomes mark 
“nucleosome-free regions” of active promoters and other regulatory 
regions. Nat Genet 41, 941–945. 
Jullien, J., Astrand, C., Szenker, E., Garrett, N., Almouzni, G., and Gurdon, 
J.B. (2012). HIRA dependent H3.3 deposition is required for 
transcriptional reprogramming following nuclear transfer to Xenopus 
oocytes. Epigenet Chromat 5, 17. 
Khuong-Quang, D.A., Buczkowicz, P., Rakopoulos, P., Liu, X.Y., 
Fontebasso, A.M., Bouffet, E., Bartels, U., Albrecht, S., 
Schwartzentruber, J., Letourneau, L., Bourgey, M., Bourque, G., 
Montpetit, A., Bourret, G., Lepage, P., Fleming, A., Lichter, P., Kool, 
M., von Deimling, A., Sturm, D., Korshunov, A., Faury, D., Jones, 
D.T., Majewski, J., Pfister, S.M., Jabado, N., and Hawkins, C. (2012). 
K27M mutation in histone H3.3 defines clinically and biologically 
distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta 
Neuropathol 124, 439–447. 
Kouzarides, T. (2007). Chromatin modifications and their function. Cell 
128, 693–705. 
 Xiong, C., et al.   Sci China Life Sci   March (2016) Vol.59 No.3 255 
Kraushaar, D.C., Jin, W., Maunakea, A., Abraham, B., Ha, M., and Zhao, 
K. (2013). Genome-wide incorporation dynamics reveal distinct 
categories of turnover for the histone variant H3.3. Genome Biol 14, 
R121. 
Ladendorff, N.E., Wu, S., and Lipsick, J.S. (2001). BS69, an adenovirus 
E1A-associated protein, inhibits the transcriptional activity of c-Myb. 
Oncogene 20, 125–132. 
Lewis, P.W., Elsaesser, S.J., Noh, K.M., Stadler, S.C., and Allis, C.D. 
(2010). Daxx is an H3.3-specific histone chaperone and cooperates with 
ATRX in replication-independent chromatin assembly at telomeres. 
Proc Natl Acad Sci USA 107, 14075–14080. 
Lewis, P.W., Müller, M.M., Koletsky, M.S., Cordero, F., Lin, S., 
Banaszynski, L.A., Garcia, B.A., Muir, T.W., Becher, O.J., and Allis, 
C.D. (2013). Inhibition of PRC2 activity by a gain-of-function H3 
mutation found in pediatric glioblastoma. Science 340, 857–861. 
Li, G., Margueron, R., Hu, G., Stokes, D., Wang, Y.H., and Reinberg, D. 
(2010). Highly compacted chromatin formed in vitro reflects the 
dynamics of transcription activation in vivo. Mol Cell 38, 41–53. 
Li, Q., Burgess, R., and Zhang, Z. (2013). All roads lead to chromatin: 
multiple pathways for histone deposition. Biochim Biophys Acta 1819, 
238–246. 
Lickwar, C.R., Mueller, F., Hanlon, S.E., McNally, J.G., and Lieb, J.D. 
(2012). Genome-wide protein-DNA binding dynamics suggest a 
molecular clutch for transcription factor function. Nature 484, 251–255. 
Lin, C.J., Conti, M., and Ramalho-Santos, M. (2013). Histone variant H3.3 
maintains a decondensed chromatin state essential for mouse 
preimplantation development. Development 140, 3624–3634. 
Lin, C.J., Koh, F.M., Wong, P., Conti, M., and Ramalho-Santos, M. 
(2014). Hira-mediated H3.3 incorporation is required for DNA 
replication and ribosomal RNA transcription in the mouse zygote. Dev 
Cell 30, 268–279. 
Liu, C.P., Xiong, C., Wang, M., Yu, Z., Yang, N., Chen, P., Zhang, Z., Li, 
G., and Xu, R.M. (2012). Structure of the variant histone H3.3-H4 
heterodimer in complex with its chaperone DAXX. Nat Struct Mol Biol 
19, 1287–1292. 
Loppin, B., Bonnefoy, E., Anselme, C., Laurencon, A., Karr, T.L., and 
Couble, P. (2005). The histone H3.3 chaperone HIRA is essential for 
chromatin assembly in the male pronucleus. Nature 437, 1386–1390. 
Luger, K., Mader, A.W., Richmond, R.K., Sargent, D.F., and Richmond, 
T.J. (1997). Crystal structure of the nucleosome core particle at 
2.8[thinsp]A resolution. Nature 389, 251–260. 
Marzluff, W.F., Gongidi, P., Woods, K.R., Jin, J., and Maltais, L.J. (2002). 
The human and mouse replication-dependent histone genes. Genomics 
80, 487–498. 
Mehta, S., Huillard, E., Kesari, S., Maire, C.L., Golebiowski, D., 
Harrington, E.P., Alberta, J.A., Kane, M.F., Theisen, M., Ligon, K.L., 
Rowitch, D.H., and Stiles, C.D. (2011). The central nervous 
system-restricted transcription factor Olig2 opposes p53 responses to 
genotoxic damage in neural progenitors and malignant glioma. Cancer 
Cell 19, 359–371. 
Meyer, R.E., Delaage, M., Rosset, R., Capri, M., and Ait-Ahmed, O. 
(2010). A single mutation results in diploid gamete formation and 
parthenogenesis in a Drosophila yemanuclein-alpha meiosis I defective 
mutant. BMC Genet 11, 104. 
Michaelson, J.S., Bader, D., Kuo, F., Kozak, C., and Leder, P. (1999). Loss 
of Daxx, a promiscuously interacting protein, results in extensive 
apoptosis in early mouse development. Genes Dev 13, 1918–1923. 
Mito, Y., Henikoff, J.G., and Henikoff, S. (2007). Histone replacement 
marks the boundaries of cis-regulatory domains. Science 315, 
1408–1411. 
Ng, R.K., and Gurdon, J.B. (2008). Epigenetic memory of an active gene 
state depends on histone H3.3 incorporation into chromatin in the 
absence of transcription. Nat Cell Biol 10, 102–109. 
Paugh, B.S., Zhu, X., Qu, C., Endersby, R., Diaz, A.K., Zhang, J., Bax, 
D.A., Carvalho, D., Reis, R.M., Onar-Thomas, A., Broniscer, A., 
Wetmore, C., Zhang, J., Jones, C., Ellison, D.W., and Baker, S.J. 
(2013). Novel oncogenic PDGFRA mutations in pediatric high-grade 
gliomas. Cancer Res 73, 6219–6229. 
Roberts, C., Sutherland, H.F., Farmer, H., Kimber, W., Halford, S., Carey, 
A., Brickman, J.M., Wynshaw-Boris, A., and Scambler, P.J. (2002). 
Targeted mutagenesis of the Hira gene results in gastrulation defects 
and patterning abnormalities of mesoendodermal derivatives prior to 
early embryonic lethality. Mol Cell Biol 22, 2318–2328. 
Sakai, A., Schwartz, B.E., Goldstein, S., and Ahmad, K. (2009). 
Transcriptional and developmental functions of the H3.3 histone variant 
in Drosophila. Curr Biol 19, 1816–1820. 
Santenard, A., Ziegler-Birling, C., Koch, M., Tora, L., Bannister, A.J., and 
Torres-Padilla, M.E. (2010). Heterochromatin formation in the mouse 
embryo requires critical residues of the histone variant H3.3. Nat Cell 
Biol 12, 853–862. 
Schwartzentruber, J., Korshunov, A., Liu, X.-Y., Jones, D.T.W., Pfaff, E., 
Jacob, K., Sturm, D., Fontebasso, A.M., Quang, D.-A.K., Tonjes, M., 
Hovestadt, V., Albrecht, S., Kool, M., Nantel, A., Konermann, C., 
Lindroth, A., Jager, N., Rausch, T., Ryzhova, M., Korbel, J.O., 
Hielscher, T., Hauser, P., Garami, M., Klekner, A., Bognar, L., 
Ebinger, M., Schuhmann, M.U., Scheurlen, W., Pekrun, A., Fruhwald, 
M.C., Roggendorf, W., Kramm, C., Durken, M., Atkinson, J., Lepage, 
P., Montpetit, A., Zakrzewska, M., Zakrzewski, K., Liberski, P.P., 
Dong, Z., Siegel, P., Kulozik, A.E., Zapatka, M., Guha, A., Malkin, D., 
Felsberg, J., Reifenberger, G., von Deimling, A., Ichimura, K., Collins, 
V.P., Witt, H., Milde, T., Witt, O., Zhang, C., Castelo-Branco, P., 
Lichter, P., Faury, D., Tabori, U., Plass, C., Majewski, J., Pfister, S.M., 
and Jabado, N. (2012). Driver mutations in histone H3.3 and chromatin 
remodelling genes in paediatric glioblastoma. Nature 482, 226–231. 
Steffen, P.A., and Ringrose, L. (2014). What are memories made of? How 
Polycomb and Trithorax proteins mediate epigenetic memory. Nat Rev 
Mol Cell Biol 15, 340–356. 
Straub, T., Dahlsveen, I.K., and Becker, P.B. (2005). Dosage compensation 
in flies: mechanism, models, mystery. FEBS Lett 579, 3258–3263. 
Sturm, D., Witt, H., Hovestadt, V., Khuong-Quang, D.A., Jones, D.T., 
Konermann, C., Pfaff, E., Tonjes, M., Sill, M., Bender, S., Kool, M., 
Zapatka, M., Becker, N., Zucknick, M., Hielscher, T., Liu, X.Y., 
Fontebasso, A.M., Ryzhova, M., Albrecht, S., Jacob, K., Wolter, M., 
Ebinger, M., Schuhmann, M.U., van Meter, T., Fruhwald, M.C., Hauch, 
H., Pekrun, A., Radlwimmer, B., Niehues, T., von Komorowski, G., 
Durken, M., Kulozik, A.E., Madden, J., Donson, A., Foreman, N.K., 
Drissi, R., Fouladi, M., Scheurlen, W., von Deimling, A., Monoranu, 
C., Roggendorf, W., Herold-Mende, C., Unterberg, A., Kramm, C.M., 
Felsberg, J., Hartmann, C., Wiestler, B., Wick, W., Milde, T., Witt, O., 
Lindroth, A.M., Schwartzentruber, J., Faury, D., Fleming, A., 
Zakrzewska, M., Liberski, P.P., Zakrzewski, K., Hauser, P., Garami, 
M., Klekner, A., Bognar, L., Morrissy, S., Cavalli, F., Taylor, M.D., 
van Sluis, P., Koster, J., Versteeg, R., Volckmann, R., Mikkelsen, T., 
Aldape, K., Reifenberger, G., Collins, V.P., Majewski, J., Korshunov, 
A., Lichter, P., Plass, C., Jabado, N., and Pfister, S.M. (2012). Hotspot 
mutations in H3F3A and IDH1 define distinct epigenetic and biological 
subgroups of glioblastoma. Cancer Cell 22, 425–437. 
Szenker, E., Lacoste, N., and Almouzni, G. (2012). A developmental 
requirement for HIRA-dependent H3.3 deposition revealed at 
gastrulation in Xenopus. Cell Rep 1, 730–740. 
Szenker, E., Ray-Gallet, D., and Almouzni, G. (2011). The double face of 
the histone variant H3.3. Cell Res 21, 421–434. 
Tagami, H., Ray-Gallet, D., Almouzni, G., and Nakatani, Y. (2004). 
Histone H3.1 and H3.3 complexes mediate nucleosome assembly 
pathways dependent or independent of DNA synthesis. Cell 116, 
51–61. 
Tang, M.C., Jacobs, S.A., Mattiske, D.M., Soh, Y.M., Graham, A.N., Tran, 
A., Lim, S.L., Hudson, D.F., Kalitsis, P., O’Bryan, M.K., Wong, L.H., 
and Mann, J.R. (2015). Contribution of the two genes encoding histone 
variant H3.3 to viability and fertility in mice. PLoS Genet 11, 
e1004964. 
Taylor, K.R., Mackay, A., Truffaux, N., Butterfield, Y.S., Morozova, O., 
Philippe, C., Castel, D., Grasso, C.S., Vinci, M., Carvalho, D., 
Carcaboso, A.M., de Torres, C., Cruz, O., Mora, J., Entz-Werle, N., 
Ingram, W.J., Monje, M., Hargrave, D., Bullock, A.N., Puget, S., Yip, 
S., Jones, C., and Grill, J. (2014). Recurrent activating ACVR1 
mutations in diffuse intrinsic pontine glioma. Nat Genet 46, 457–461. 
Thakar, A., Gupta, P., Ishibashi, T., Finn, R., Silva-Moreno, B., Uchiyama, 
256 Xiong, C., et al.   Sci China Life Sci   March (2016) Vol.59 No.3 
S., Fukui, K., Tomschik, M., Ausio, J., and Zlatanova, J. (2009). H2A.Z 
and H3.3 histone variants affect nucleosome structure: biochemical and 
biophysical studies. Biochemistry 48, 10852–10857. 
the St. Jude Children’s Research Hospital-Washington University Pediatric 
Cancer Genome, P. (2014). The genomic landscape of diffuse intrinsic 
pontine glioma and pediatric non-brainstem high-grade glioma. Nat 
Genet 46, 444–450. 
van der Heijden, G.W., Derijck, A.A.H.A., Posfai, E., Giele, M., Pelczar, 
P., Ramos, L., Wansink, D.G., van der Vlag, J., Peters, A.H.F.M., and 
de Boer, P. (2007). Chromosome-wide nucleosome replacement and 
H3.3 incorporation during mammalian meiotic sex chromosome 
inactivation. Nat Genet 39, 251–258. 
Vezzoli, A., Bonadies, N., Allen, M.D., Freund, S.M.V., Santiveri, C.M., 
Kvinlaug, B.T., Huntly, B.J.P., Gottgens, B., and Bycroft, M. (2010). 
Molecular basis of histone H3K36me3 recognition by the PWWP 
domain of Brpf1. Nat Struct Mol Biol 17, 617–619. 
Voon, H.P., Hughes, J.R., Rode, C., De La Rosa-Velazquez, I.A., 
Jenuwein, T., Feil, R., Higgs, D.R., and Gibbons, R.J. (2015). ATRX 
plays a key role in maintaining silencing at interstitial heterochromatic 
loci and imprinted genes. Cell Rep 11, 405–418. 
Wagner, E.J., and Carpenter, P.B. (2012). Understanding the language of 
Lys36 methylation at histone H3. Nat Rev Mol Cell Biol 13, 115–126. 
Wen, D., Banaszynski, L.A., Liu, Y., Geng, F., Noh, K.M., Xiang, J., 
Elemento, O., Rosenwaks, Z., Allis, C.D., and Rafii, S. (2014a). 
Histone variant H3.3 is an essential maternal factor for oocyte 
reprogramming. Proc Natl Acad Sci USA 111, 7325–7330. 
Wen, D., Noh, K.M., Goldberg, A.D., Allis, C.D., Rosenwaks, Z., Rafii, S., 
and Banaszynski, L.A. (2014b). Genome editing a mouse locus 
encoding a variant histone, H3.3B, to report on its expression in live 
animals. Genesis 52, 959–966. 
Wen, H., Li, Y., Xi, Y., Jiang, S., Stratton, S., Peng, D., Tanaka, K., Ren, 
Y., Xia, Z., Wu, J., Li, B., Barton, M.C., Li, W., Li, H., and Shi, X. 
(2014c). ZMYND11 links histone H3.3K36me3 to transcription 
elongation and tumour suppression. Nature 508, 263–268. 
Witt, O., Albig, W., and Doenecke, D. (1997). Transcriptional regulation 
of the human replacement histone gene H3.3B. FEBS Lett 408, 
255–260. 
Wong, L.H., McGhie, J.D., Sim, M., Anderson, M.A., Ahn, S., Hannan, 
R.D., George, A.J., Morgan, K.A., Mann, J.R., and Choo, K.H. (2010). 
ATRX interacts with H3.3 in maintaining telomere structural integrity 
in pluripotent embryonic stem cells. Genome Res 20, 351–360. 
Wong, L.H., Ren, H., Williams, E., McGhie, J., Ahn, S., Sim, M., Tam, A., 
Earle, E., Anderson, M.A., Mann, J., and Choo, K.H. (2009). Histone 
H3.3 incorporation provides a unique and functionally essential 
telomeric chromatin in embryonic stem cells. Genome Res 19, 
404–414. 
Wu, G., Broniscer, A., McEachron, T.A., Lu, C., Paugh, B.S., Becksfort, 
J., Qu, C., Ding, L., Huether, R., Parker, M., Zhang, J., Gajjar, A., 
Dyer, M.A., Mullighan, C.G., Gilbertson, R.J., Mardis, E.R., Wilson, 
R.K., Downing, J.R., Ellison, D.W., Zhang, J., and Baker, S.J. (2012). 
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine 
gliomas and non-brainstem glioblastomas. Nat Genet 44, 251–253. 
Wu, G., Diaz, A.K., Paugh, B.S., Rankin, S.L., Ju, B., Li, Y., Zhu, X., Qu, 
C., Chen, X., Zhang, J., Easton, J., Edmonson, M., Ma, X., Lu, C., 
Nagahawatte, P., Hedlund, E., Rusch, M., Pounds, S., Lin, T., 
Onar-Thomas, A., Huether, R., Kriwacki, R., Parker, M., Gupta, P., 
Becksfort, J., Wei, L., Mulder, H.L., Boggs, K., Vadodaria, B., 
Yergeau, D., Russell, J.C., Ochoa, K., Fulton, R.S., Fulton, L.L., Jones, 
C., Boop, F.A., Broniscer, A., Wetmore, C., Gajjar, A., Ding, L., 
Mardis, E.R., Wilson, R.K., Taylor, M.R., Downing, J.R., Ellison, 
D.W., Zhang, J., and Baker, S.J. (2014). The genomic landscape of 
diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade 
glioma. Nat Genet 46, 444–450. 
Wu, H., Zeng, H., Lam, R., Tempel, W., Amaya, M.F., Xu, C., 
Dombrovski, L., Qiu, W., Wang, Y., and Min, J. (2011). Structural and 
histone binding ability characterizations of human PWWP domains. 
PLoS One 6, e18919. 
Yang, J.H., Song, Y., Seol, J.H., Park, J.Y., Yang, Y.J., Han, J.W., Youn, 
H.D., and Cho, E.J. (2011). Myogenic transcriptional activation of 
MyoD mediated by replication-independent histone deposition. Proc 
Natl Acad Sci USA 108, 85–90. 
Yuen, B.T., Bush, K.M., Barrilleaux, B.L., Cotterman, R., and Knoepfler, 
P.S. (2014). Histone H3.3 regulates dynamic chromatin states during 
spermatogenesis. Development 141, 3483–3494. 
Yuen, B.T., and Knoepfler, P.S. (2013). Histone H3.3 mutations: a variant 
path to cancer. Cancer Cell 24, 567–574. 
 
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction 
in any medium, provided the original author(s) and source are credited. 
